CPL Biologicals Breaks Ground on Influenza Vaccine Plant

CPL Biologicals broke ground in fall of 2009 on an influenza vaccine manufacturing facility in Ahmedabad, India. The 25,000-sf building will be operational in the first quarter of 2010. The facility will use virus-like particle (VLP) vaccine technology to produce commercial-scale quantities of VLP-based influenza vaccines. The plant will be able to produce over 60 million doses annually at full capacity. CPL Biologicals is a joint venture of Novavax and Cadila Pharmaceuticals of India.